CD79A and COVID-19: The mechanism of COVID-19-induced coagulopathy is not yet well established; however, a case series in China in the early period of the pandemic reported that three ICU patients with COVID-19 had positive aPLs, including anticardiolipin IgA and anti-β2-glycoprotein IgA and IgG, and all of them had multiple cerebral infarcts [7].